The relative safety and effectiveness of different epoetin drugs for treating anaemia in people with chronic kidney disease
Many patients with moderate or severe chronic kidney disease will develop anaemia and a variety of treatments are available. In February 2023, the Cochrane Review of studies testing a range of erythropoietin drugs was updated and we asked first author, Edmund Chung from The Children ' s Hospital at Westmead in Australia to tell us about the latest findings in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - May 11, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts
Which combinations of medicines are best for the prevention and treatment of anaemia in people with cancer?
Cochrane has produced several systematic reviews of interventions that might help people suffering from anaemia. In this podcast, Claire Iannizzi talks with lead author Anne Adams, both from the University Hospital Cologne in Germany, about a review of intravenous, oral or no iron in combination with erythropoiesis-stimulating agents for cancer patients with anaemia, which was published for the first time in June 2022. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - September 23, 2022 Category: General Medicine Authors: Cochrane Source Type: podcasts
Exercise Training for HFpEF, Blood Transfusion for AMI and Anemia, Review of Hip and Knee OA, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 9, 2021 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 9, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Vitamin C and Thiamine for Septic Shock, IV Iron Formulations for Fe-Deficiency Anemia, Home NIV for COPD, and more
Editor's Summary by Anne Cappola, MD, Associate Editor for JAMA, the Journal of the American Medical Association, for the February 04, 2020 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 4, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Effect of Diet on NAFLD in Adolescents, HSCT for Sickle Cell Anemia, ASA for Primary Prevention and CVD, Review of Breast Cancer Treatment, and more
Editor's Summary by Jody Zylke, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the January 22, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 22, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Advances in transplantation and drug treatments for idiopathic aplastic anemia
Treating aplastic anemia (AA) with transplantation in a pediatric population is deemed relatively complicated, according to Rgis Peffault de Latour, MD, PhD, of Saint Louis Hospital, Paris, France. H...
Author: VJHemOnc
Added: 09/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 7, 2018 Category: Cancer & Oncology Source Type: podcasts
Challenges in the management of idiopathic aplastic anemia
Rgis Peffault de Latour, MD, PhD, from Saint Louis Hospital, Paris, France, discusses the main challenges in managing patients with idiopathic aplastic anemia. He identifies three key challenges, inc...
Author: VJHemOnc
Added: 09/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 7, 2018 Category: Cancer & Oncology Source Type: podcasts
Iron and inflammation in anemia and sickle cell disease
Speaking from the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden, Dr Francesca Vinchi, of the Iron Research Program, New York Blood Center, N...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Treatment challenges in myelofibrosis
Treating myelofibrosis is accompanied by several complications that must be considered, including thrombocytopenia and anemia. In this video, recorded at the 23rd Congress of the European Hematology A...
Author: VJHemOnc
Added: 07/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 23, 2018 Category: Cancer & Oncology Source Type: podcasts
Current techniques for treating iron-deficiency anemia
Iron-deficiency anemia is an extremely common form of anemia. Here, Maria Domenica Cappellini, MD, of the University of Milan-Foundation IRCCS Policlinico Hospital, Milan, Italy, speaks about differen...
Author: VJHemOnc
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
Treating aplastic anemia in developing countries
Aplastic anemia (AA) results in T-cells attacking bone marrow stem cells, causing loss of all blood cell types. Generally, this condition is treated with a stem cell transplant in combination with ant...
Author: VJHemOnc
Added: 07/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Treating aplastic anemia in developing countries
Aplastic anemia (AA) results in T-cells attacking bone marrow stem cells, causing loss of all blood cell types. Generally, this condition is treated with a stem cell transplant in combination with ant...
Author: VJHemOnc
Added: 07/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2018 Category: Cancer & Oncology Source Type: podcasts
SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia at AACR 2018.
Author: Cancer-News
Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts
